Consolidated Financial Statements for the Third Quarter Ended December 31, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED]
About Us Message from the president Corporate Data and Subsidiaries Corporate Executives Directions to Takara Bio Quality Assurance Policy Consolidated Subsidiaries Business Outline Bioindustry Gene Therapy News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline... Read more